Journal of Developing Drugs
Open Access
ISSN: 2329-6631
+44 1478 350008
ISSN: 2329-6631
+44 1478 350008
Abdul Nabeel Khan
University of Sunderland, UK
Posters & Accepted Abstracts: J Develop Drugs
The monarchy of drug delivery has firmly entered into a novel approach termed to be as nanotechnology. The reason for appraising the drug delivery system is to maximize the therapeutic activity and minimize the untoward side effects. Micelles, polymeric nanoparticles, and dendrimers are the basis of remarkable drug delivery system. However, polymeric carbon nanotubes and many others demonstrate a broad variety of useful properties. Augmenting the integration of nanomaterials into drug delivery systems will require standardized methods for their classification, as well as protocols for their handling. The development of such drug carriers will require a greater understanding of both the surface chemistry of nanomaterials and the interaction chemistry of these nanomaterials with biological systems, hence can only be achieved through collaborative efforts among scientists in different disciplines. Nanotechnology is an emerging field with the potential to revolutionize drug delivery. Advances in this area have allowed some nanomedicines in the market to achieve desirable pharmacokinetic properties which reduce toxicity and improve patient compliance, as well as clinical outcomes. Integration of nanoparticulate drug delivery technologies in pre-formulation work, not only accelerates the development of new therapeutic moieties, but also helps in the reduction of attrition of new molecular entities caused by undesirable biopharmaceutical and pharmacokinetic properties.